Home › Funds › Beutel, Goodman & Co Ltd. › ELV

Beutel, Goodman & Co Ltd. position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Beutel, Goodman & Co Ltd. reported holding 429,951 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$167.2M, representing 1.32% of its reported portfolio and ranking #37 among its reported holdings. Beutel, Goodman & Co Ltd. has disclosed ELV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)429.95K sh
Reported value held$167.17M
Portfolio Weight1.32%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Beutel, Goodman & Co Ltd.'s ELV position evolved

Beutel, Goodman & Co Ltd. first disclosed a stake in ELV in Q2 2025 at 753,653 shares (US$293.1M). Across 6 filings, Beutel, Goodman & Co Ltd. increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 429,951 shares valued at US$167.2M — a reduction of -148,512 shares quarter over quarter.. Notable position changes include a 35% trim in Q2 2026 (shares were roughly flat over the following quarter), a 26% trim in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 753.65K $293.14M New
Q3 2025 717.82K $231.94M Reduce
Q4 2025 817.90K $286.71M Add
Q1 2026 886.72K $259.59M Add
Q2 2026 578.46K $223.71M Reduce
Q3 2026 429.95K $167.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Beutel, Goodman & Co Ltd. held ELV?

Beutel, Goodman & Co Ltd. has disclosed ELV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Beutel, Goodman & Co Ltd.'s current position in ELV?

As of Q3 2026, Beutel, Goodman & Co Ltd. holds 429.95K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $167.17M, representing 1.32% of its reported portfolio and ranking #37.

Has Beutel, Goodman & Co Ltd. been buying or selling ELV?

In the latest 13F filing (Q3 2026), Beutel, Goodman & Co Ltd. reduced its position in ELV.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.